Michael W. Michelson - 24 Apr 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: Director
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 24 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 26 Apr 2023, 17:10:12 UTC
Previous filing: 04 Apr 2023
Next filing: 16 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+1,187	+14%	$0.000000	9,387	24 Apr 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents common stock underlying 663 restricted share units attributable to an annual director equity award and 524 restricted share units received in lieu of annual cash retainers for service as a director and as independent presiding director. The restricted share units shall vest on the sooner of the date of the 2024 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

Content

Represents common stock underlying 663 restricted share units attributable to an annual director equity award and 524 restricted share units received in lieu of annual cash retainers for service as a director and as independent presiding director. The restricted share units shall vest on the sooner of the date of the 2024 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.